DRKS00027830
Recruiting
Not Applicable
SEMM - Systematic Assessment of Menière's Disease: Prospective Observational Study - SEMM
Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, LMU Klinikum0 sites999 target enrollmentMarch 28, 2022
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- H81.0
- Sponsor
- Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, LMU Klinikum
- Enrollment
- 999
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with Menière's Disease who are treated in the neurotology outpatient clinic at the LMU Clinic and had given informed consent to participation in the study.
Exclusion Criteria
- •Vestibular migraines, other vestibular diseases.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 1
Correlation criteria diagnosis of Meniere's disease between conventional criteria and new staging with vestibular function testMeniere's diseases disease, Vestibular function testsTCTR20220606003Khon Kaen University42
Completed
Not Applicable
Comprehensive Evaluation in Patients With Meniere's DiseaseMeniere DiseasePsychosocial ProblemPhysical DisabilityQuality of LifeNCT05844657Hacettepe University34
Not yet recruiting
Not Applicable
Menier's Disease - Bone Density StudyMeniere DiseaseOsteoporosisOsteopeniaVitamin D DeficiencyVestibular DisorderNCT05322538HaEmek Medical Center, Israel60
Recruiting
Phase 3
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's DiseaseMeniere DiseaseNCT05851508Leiden University Medical Center148
Active, not recruiting
Phase 1
SERENDEM study: high dose biotin in patients suffering from disability related to peripheral nerve diseaseschronic inflammatory demyelinating polyradiculoneuropathy, demyelinating neuropathy associated with immunoglobulin M (IgM) monoclonal gammopathy and antibodies against myelin-associated glycoprotein (MAG), Charcot Marie Tooth Ia (CMT Ia) neuropathyMedDRA version: 18.1Level: LLTClassification code 10066137Term: Anti-MAG neuropathySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1Level: PTClassification code 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathySystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1Level: LLTClassification code 10008414Term: Charcot-Marie-Tooth diseaseSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2015-001150-15-FRMEDDAY PHARMACEUTICALS15